Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells

被引:124
作者
Chen, CS
Sun, XD
Guo, P
Dong, XY
Sethi, P
Cheng, XH
Zhou, J
Ling, JX
Simons, JW
Lingrel, JB
Dong, JT [1 ]
机构
[1] Emory Univ, Sch Med, Winship Canc Ctr, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Hematol & Oncol, Atlanta, GA 30322 USA
[3] Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30322 USA
[4] Emory Univ, Sch Med, Program Genet & Mol Biol, Atlanta, GA 30322 USA
[5] Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China
[6] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45221 USA
关键词
D O I
10.1074/jbc.M506183200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcription factor KLF5 plays an important role in human carcinogenesis. In epithelial cells, the KLF5 protein is tightly regulated by the ubiquitin-proteasome pathway. To better understand the mechanisms for the regulation of KLF5 protein, we identified and characterized an E3 ubiquitin ligase for KLF5, i.e. WWP1. We found that WWP1 formed a protein complex with KLF5 in vivo and in vitro. Furthermore, WWP1 mediated the ubiquitination and degradation of KLF5, and the catalytic cysteine residue of WWP1 is essential for its function. A PY motif in a transactivation domain of KLF5 is necessary for its interaction with WWP1. Finally, WWP1 was amplified and overexpressed in some cancer cell lines from the prostate and breast, which negatively regulated the function of KLF5 in gene regulation. These findings not only established WWP1 as an E3 ubiquitin ligase for KLF5, they also further implicated the KLF5 pathway in human carcinogenesis.
引用
收藏
页码:41553 / 41561
页数:9
相关论文
共 45 条
  • [1] Regulation of the cardiac voltage-gated Na+ channel (H1) by the ubiquitin-protein ligase Nedd4
    Abriel, H
    Kamynina, E
    Horisberger, JD
    Staub, O
    [J]. FEBS LETTERS, 2000, 466 (2-3) : 377 - 380
  • [2] Positive- and negative-acting Kruppel-like transcription factors bind a transforming growth factor β control element required for expression of the smooth muscle cell differentiation marker SM22α in vivo
    Adam, PJ
    Regan, CP
    Hautmann, MB
    Owens, GK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (48) : 37798 - 37806
  • [3] Regulation of platelet-derived growth factor-A chain by Kruppel-like factor 5 -: New pathway of cooperative activation with nuclear factor-κB
    Aizawa, K
    Suzuki, T
    Kada, N
    Ishihara, A
    Kawai-Kowase, K
    Matsumura, T
    Sasaki, K
    Munemasa, Y
    Manabe, I
    Kurabayashi, M
    Collins, T
    Nagai, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (01) : 70 - 76
  • [4] Intestinal tumor progression is associated with altered function of KLF5
    Bateman, NW
    Tan, DF
    Pestell, RG
    Black, JD
    Black, AR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) : 12093 - 12101
  • [5] Identification and validation of novel ERBB2 (HER2, NEU) targets including genes involved in angiogenesis
    Beckers, J
    Herrmann, F
    Rieger, S
    Drobyshev, AL
    Horsch, M
    de Angelis, MH
    Seliger, B
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (04) : 590 - 597
  • [6] BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer - Potential therapeutic targets
    Calhoun, ES
    Jones, JB
    Ashfaq, R
    Adsay, V
    Baker, SJ
    Valentine, V
    Hempen, PM
    Hilgers, W
    Yeo, CJ
    Hruban, RH
    Kern, SE
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (04) : 1255 - 1260
  • [7] All-trans retinoic acid inhibits proliferation of intestinal epithelial cells by inhibiting expression of the gene encoding Kruppel-like factor 5
    Chanchevalap, S
    Nandan, MO
    Merlin, D
    Yang, VW
    [J]. FEBS LETTERS, 2004, 578 (1-2): : 99 - 105
  • [8] A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer
    Chen, C
    Bhalala, HV
    Qiao, H
    Dong, JT
    [J]. ONCOGENE, 2002, 21 (43) : 6567 - 6572
  • [9] KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer
    Chen, C
    Bhalala, HV
    Vessella, RL
    Dong, JT
    [J]. PROSTATE, 2003, 55 (02) : 81 - 88
  • [10] Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells
    Chen, CS
    Sun, XD
    Ran, QM
    Wilkinson, KD
    Murphy, TJ
    Simons, JW
    Dong, JT
    [J]. ONCOGENE, 2005, 24 (20) : 3319 - 3327